ADC Therapeutics S.A. (ADCT)
NYSE: ADCT
· Real-Time Price · USD
3.46
-0.10 (-2.81%)
At close: Sep 25, 2025, 10:17 AM
ADC Therapeutics S.A. Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ADCT stock have an median target of 8, with a low estimate of 8 and a high estimate of 10. The median target predicts an increase of 131.21% from the current stock price of 3.46.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 8 | 8.67 | 8 | 10 |
| Change | 131.21% | 150.58% | 131.21% | 189.02% |
Latest Analyst Insight Report
RBC Capital maintains an Outperform rating on ADC ... Unlock content with Pro Subscription
Updated Jun 20, 2025
| Rating | Jan 25 | Feb 25 | Mar 25 | May 25 | Jun 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 0 |
| Buy | 1 | 1 | 3 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 3 | 1 | 2 | 1 |
Financial Forecast this Year
Revenue This Year
78.73M
from 70.84M
Increased by 11.1%
Revenue Next Year
80.58M
from 78.73M
Increased by 2.4%
EPS This Year
-1.52
from -1.62
Increased by 6.2%
EPS Next Year
-1.31
from -1.52
Increased by 13.8%